Lynparza (olaparib)

About AstraZeneca

AstraZeneca is one of the world's largest pharmaceutical companies, headquartered in Cambridge, UK, with a market capitalization of approximately $285 billion. The company focuses on transformative science including next-generation therapeutics, AI-driven drug discovery, and personalized medicine approaches. AstraZeneca reported strong commercial performance in 2025 with 16 positive Phase 3 study results announced during the year, demonstrating continued pipeline strength across multiple therapeutic areas.

About Merck

Merck & Co., Inc. is a leading research-intensive biopharmaceutical company founded in 1891 and headquartered in Rahway, New Jersey. With a market valuation of approximately $282 billion, the company has built a legacy of breakthrough medicines and vaccines, including the blockbuster cancer immunotherapy Keytruda and vaccines like Gardasil. Merck operates globally, reaching 92% of the world's countries with its products and serving over 450 million people with medicines and vaccines in 2024.

Therapeutic Areas